{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:36:18Z","timestamp":1756384578218},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T00:00:00Z","timestamp":1424304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00393-014-1501-1","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T14:49:19Z","timestamp":1424184559000},"page":"137-145","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Differenzialdiagnose der Transaminasenerh\u00f6hung bei rheumatischen Erkrankungen"],"prefix":"10.1007","volume":"74","author":[{"given":"W.-J.","family":"Mayet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,19]]},"reference":[{"key":"1501_CR1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/223472a0","volume":"223","author":"Cantor","year":"1969","unstructured":"Cantor H, Dumont A (1969) Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 223:472\u2013476","journal-title":"Nature"},{"key":"1501_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00393-005-0701-0","volume":"64","author":"Wiegard","year":"2005","unstructured":"Wiegard C, Lohse AW (2005) Leber und Rheuma. Z Rheumatol 64:26\u201331","journal-title":"Z Rheumatol"},{"key":"1501_CR3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/ard.2002.001826","volume":"63","author":"Abraham","year":"2004","unstructured":"Abraham S, Begum S, Isenberg D (2004) Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 63:123\u2013129","journal-title":"Ann Rheum Dis"},{"key":"1501_CR4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.berh.2004.05.004","volume":"18","author":"Kadar","year":"2004","unstructured":"Kadar J, Petrovicz E (2004) Adult-onset Stills disease. Best Pract Clin Rheumatol 18:663\u2013676","journal-title":"Best Pract Clin Rheumatol"},{"key":"1501_CR5","first-page":"244","volume":"46","author":"Van","year":"1996","unstructured":"Van Hoek B (1996) The spectrum of liver disease in systemic lupus erythematosus. Nether J Med 46:244\u2013253","journal-title":"Nether J Med"},{"key":"1501_CR6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/096120339300200117","volume":"2","author":"Milan-Mon","year":"1993","unstructured":"Milan-Mon A, Porto JL, Novo C (1993) Hepatic infarction in a pregnant patient with the primary anti-phospholipid syndrome. Lupus 2:275","journal-title":"Lupus"},{"key":"1501_CR7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10067-002-0689-7","volume":"22","author":"Iwai","year":"2003","unstructured":"Iwai M, Harada Y, Ishii M et al (2003) Autoimmune hepatitis in a patient with systemic lupus erythematosus. Clin Rheumatol 22:234\u2013236","journal-title":"Clin Rheumatol"},{"key":"1501_CR8","first-page":"313","volume":"51","author":"Czaja","year":"2005","unstructured":"Czaja A (2005) Diverse manifestations and evolving treatments of autoimmune hepatitis. Minerva Gastroenterol Dietol 51:313\u2013333","journal-title":"Minerva Gastroenterol Dietol"},{"key":"1501_CR9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00393-012-1116-3","volume":"72","author":"Mayet","year":"2013","unstructured":"Mayet W, Lohse AW (2013) Komorbidit\u00e4t rheumatologischer und hepatologischer Erkrankungen. Z Rheumatol 72:547\u2013554","journal-title":"Z Rheumatol"},{"key":"1501_CR10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.1840110504","volume":"11","author":"Tsianos","year":"1989","unstructured":"Tsianos E, Hoofnagle JH, Foc CPH (1989) Sj\u00f6grens syndrome in patients with primary biliary cirrhosis. Hepatology 11:730","journal-title":"Hepatology"},{"key":"1501_CR11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0168-8278(00)00060-X","volume":"34","author":"Gow","year":"2001","unstructured":"Gow P, Flemming KA, Chapman RW (2001) Primary sclerosing cholangitis associated with rheumatoid arthritis and HLA DR4: Is the association a marker of patients with progressive liver disease? J Hepatol 34:631\u2013635","journal-title":"J Hepatol"},{"key":"1501_CR12","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.83.6.1627","volume":"83","author":"Tur-Kaspa","year":"1986","unstructured":"Tur-Kaspa R, Burk RD, Shaul Y, Shafritz DA (1986) Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci U S A 83:1627\u20131631","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1501_CR13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1440-1746.1998.tb00539.x","volume":"13","author":"Liaw","year":"1998","unstructured":"Liaw Y (1998) Hepatitis viruses under immunosuppressive agents. J Gastroenterol Hepatol 13:14\u201320","journal-title":"J Gastroenterol Hepatol"},{"key":"1501_CR14","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3748\/wjg.v17.i12.1531","volume":"17","author":"Manzano-Alonso","year":"2011","unstructured":"Manzano-Alonso M, Castellano-Tortajada G (2011) Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy. World J Gastroenterol 17:1531\u20131537","journal-title":"World J Gastroenterol"},{"key":"1501_CR15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2474-9-48","volume":"9","author":"Jobanputra","year":"2008","unstructured":"Jobanputra P, Amarasena R, Maggs F (2008) Hepatotoxicity associated with sulfasalazine in inflammatory arthritis. BMC Musculoskel Dis 9:48","journal-title":"BMC Musculoskel Dis"},{"key":"1501_CR16","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/ar3085","volume":"12","author":"Quintin","year":"2010","unstructured":"Quintin E, Scoazec JY, Marotte H, Miossec P (2010) Rare incidence of methotrexate-specific lesions in liver biopsy of patients with arthritis and elevated liver enzymes. Arthritis Res Ther 12:R143","journal-title":"Arthritis Res Ther"},{"key":"1501_CR17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00393-010-0687-0","volume":"70","author":"Key\u00dfer","year":"2011","unstructured":"Key\u00dfer G (2011) Methotrexat-Toxizit\u00e4t. Mythen und Fakten. Z Rheumatol 70:108\u2013113","journal-title":"Z Rheumatol"},{"key":"1501_CR18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/BOR.0b013e3282f05b63","volume":"19","author":"Vassilopoulos","year":"2007","unstructured":"Vassilopoulos D, Calabrese LH (2007) Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections. Curr Opin Rheumatol 19:619\u2013625","journal-title":"Curr Opin Rheumatol"},{"key":"1501_CR19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","volume":"59","author":"Saag","year":"2008","unstructured":"Saag K, Teng GG, Patkar NM et al (2008) American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 59:762\u2013784","journal-title":"Arthritis Rheum"},{"key":"1501_CR20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12185-009-0359-5","volume":"90","author":"Kusumoto","year":"2009","unstructured":"Kusumoto S, Tanaka Y, Mizokami M, Ueda R (2009) Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma. Int J Hematol 90:13\u201323","journal-title":"Int J Hematol"},{"key":"1501_CR21","first-page":"9","volume":"46","author":"Kusumoto","year":"2011","unstructured":"Kusumoto S, Tanaka Y, Ueda R, Mizokami M (2011) Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy. J Gastroenterol Hepatol 46:9\u201316","journal-title":"J Gastroenterol Hepatol"},{"key":"1501_CR22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0049-0172(92)90038-F","volume":"2003","author":"Kremer","year":"1992","unstructured":"Kremer J, Koff R (1992) A debate: should patients with rheumatoid arthritis on methotrexate undergo liver biopsie? Semin Arthritis Rheum 2003:376","journal-title":"Semin Arthritis Rheum"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-014-1501-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-014-1501-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-014-1501-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:37:27Z","timestamp":1559061447000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-014-1501-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,19]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["1501"],"URL":"https:\/\/doi.org\/10.1007\/s00393-014-1501-1","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,19]]}}}